Status:
COMPLETED
Breathing Adapted Radiotherapy for Mediastinal Lymphoma
Lead Sponsor:
Peter Meidahl Petersen
Collaborating Sponsors:
University of Copenhagen
Conditions:
Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
In this study, radiation therapy plans will be made for 20 consecutive patients with mediastinal Hodgkin lymphoma or aggressive non-Hodgkin lymphoma. One plan is done using a breathing adapted pre-che...
Detailed Description
Radiotherapy using a breathing adapted therapy scan is a routine technique in breast cancer. Breathing adapted radiotherapy may also reduce radiation dose to organs at risk, e.g. heart and lung, in pa...
Eligibility Criteria
Inclusion
- Stage I/II mediastinal Hodgkin lymphoma or aggressive non-Hodgkin lymphomas
- Treatment plan includes radiotherapy
Exclusion
- Not able to comply to breathing adapted therapy
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00928096
Start Date
June 1 2009
End Date
May 1 2013
Last Update
October 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Hematology and Department of Radiation Oncology, Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark, DK2100